Big Survey 2014 Report now available Thanks to the 250 women who took part in our Big Survey in 2014 Lipoedema UK have produced this powerful report. Highlighting the difficulties in obtaining a diagnosis and lack of suitable treatments it also contains a wealth of statistics on the far reaching impact of lipoedema on lives, careers and relationships. You can view or download the report by visiting our website at http://www.lipoedema.co.uk/lipoedema-uks-big-survey/
- Lymphoedema/Chronic Oedema: Are you meeting the needs of your local population Webinar recording
Webinar: Lymphoedema/ Chronic Oedema: Are you meeting the needs of your local population? Many thanks to those of you who were able to join us on the webinar on Thursday 8 September, we hope it proved to be an interesting and useful presentation. Please find below the recording of the webinar: Lymphoedema/ Chronic Oedema – Are you meeting the needs of your local population?-20160908 1701-1Thursday, September 8, 20167:03 pm | GMT Summer Time (London, GMT+01:00) PLAY RECORDING (58 min)https://healthsector.webex.com/healthsector/ldr.php?RCID=3d13ff5babb2b9fee2e93763897101f9 We have also attached the combined responses form the questions arising from the webinar on the 8th September.
- National Lymphoedema Tarriff - Practitioner’s commissioning guidance
Fuller clinical guideline is available in the members’ area.
- News and Views Winter 2016
News and Views Winter 2016 Issue 100
- ILF Best Practice Document
ILF Best Practices
- LNNI - Lymphoedema Easy Read
Easy Read article from the Lymphoedema Network Northern Ireland to help people with learning difficulties
- LNNI 4 Key Things you can do to help your Lymphoedema
Lymphoedema Network Northern Ireland artcile to help people with learning difficulties, outlining 4 Key things you can do to help your Lymphoedema.
- National lymphoedema tariff document
This document is aimed at those responsible for commissioning services. It is an advisory docunment that covers proposed staffing levels, patient pathway and costings associated with the currently available treatments for lymphoedema.